Preliminary studies carried out at the National Heart, Lung and Blood Institute Sickle Cell Disease Reference Laboratory (NHLBI-SCDRL), NIH, at the Children's Hospital of Philadelphia (CHOP) and Xechem Research Laboratory in New Brunswick, NJ have confirmed some of the Nigerian studies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.